An investigation for investors in Biohaven Ltd. (NYSE:BHVN) shares over potential securities laws violations by Biohaven Ltd. was announced.
San Diego, CA -- (SBWIRE) -- 08/23/2023 -- Biohaven Ltd. is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Biohaven Ltd. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
New Haven, CT based Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States.
On July 27, 2023, Biohaven Ltd. announced, among other items, that "[o]n its SCA program, the FDA informed Biohaven that it would not review the recently submitted NDA application for troriluzole given that the study's primary endpoint was not met and thus, would not permit a substantive review."
Shares of Biohaven Ltd. (NYSE: BHVN) declined from $25.84 per share on June 14, 2023, to as low as $17.10 per share on July 27, 2023.
Those who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.